HomeInvestors HealthPaulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves By BOMAR ENT. November 15, 2024 FacebookTwitterPinterestWhatsApp bodnarchuk/iStock via Getty Images Paulson & Co. exited its position in AngloGold Ashanti (NYSE:AU) in Q3, according to the fund’s latest 13F filing. The fund increased its stake in Madrigal Pharmaceuticals. Paulson & Co. also reduced its position in Altice USA (ATUS) in Source link Previous articlePassive Income Strategy for Stocks and Options | Covered Calls Tutorial #stocksNext articleStock market news today: Tech gains, Dow lags on heels of slowing labor market demand | 12/5/23 latest articles explore more Macroeconomics For Investors | ft. @The Plain Bagel How to Trade Options: The Complete Guide for Beginners (Options Trading for Beginners Crash Course Book 2024) General in Nigeria Recounts Death Sentences of Sham Trial Stock market news today: Tech gains, Dow lags on heels of slowing labor market demand | 12/5/23 Passive Income Strategy for Stocks and Options | Covered Calls Tutorial #stocks I Tried Making Money Selling NFTs LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.